MX9200728A - Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. - Google Patents

Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.

Info

Publication number
MX9200728A
MX9200728A MX9200728A MX9200728A MX9200728A MX 9200728 A MX9200728 A MX 9200728A MX 9200728 A MX9200728 A MX 9200728A MX 9200728 A MX9200728 A MX 9200728A MX 9200728 A MX9200728 A MX 9200728A
Authority
MX
Mexico
Prior art keywords
skin disorders
pharmaceutical formulation
topical
adapted pharmaceutical
ion
Prior art date
Application number
MX9200728A
Other languages
English (en)
Inventor
Ernest Arthur Hill
Original Assignee
Glaxo Group Limited Glaxo Grou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited Glaxo Grou filed Critical Glaxo Group Limited Glaxo Grou
Publication of MX9200728A publication Critical patent/MX9200728A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9200728A 1991-02-22 1992-02-21 Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. MX9200728A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103764A GB9103764D0 (en) 1991-02-22 1991-02-22 Compositions

Publications (1)

Publication Number Publication Date
MX9200728A true MX9200728A (es) 1992-10-01

Family

ID=10690429

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200728A MX9200728A (es) 1991-02-22 1992-02-21 Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.

Country Status (11)

Country Link
EP (1) EP0573492B1 (es)
AT (1) ATE114244T1 (es)
AU (1) AU1277792A (es)
CA (1) CA2104677A1 (es)
DE (1) DE69200711T2 (es)
DK (1) DK0573492T3 (es)
ES (1) ES2064166T3 (es)
GB (1) GB9103764D0 (es)
GR (1) GR3015014T3 (es)
MX (1) MX9200728A (es)
WO (1) WO1992014472A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174475A (en) * 1991-03-26 1992-12-29 Glaxo Inc. Sequential dosing of antifungal and antiinflammatory compositions
GB9823036D0 (en) * 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
AR032362A1 (es) * 2000-08-14 2003-11-05 Glaxo Group Ltd Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2012023077A1 (en) * 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it

Also Published As

Publication number Publication date
AU1277792A (en) 1992-09-15
DK0573492T3 (da) 1995-01-09
WO1992014472A1 (en) 1992-09-03
EP0573492B1 (en) 1994-11-23
ATE114244T1 (de) 1994-12-15
DE69200711D1 (de) 1995-01-05
DE69200711T2 (de) 1995-03-30
ES2064166T3 (es) 1995-01-16
CA2104677A1 (en) 1992-08-23
GR3015014T3 (en) 1995-05-31
EP0573492A1 (en) 1993-12-15
GB9103764D0 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
MX9200728A (es) Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
ES2133785T3 (es) Inhibidores de metaloproteinasas.
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
AU1750283A (en) Hair growing agent
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
EE9900162A (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
NO302170B1 (no) Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav
AU3401093A (en) Therapeutic agent for threatened abortion
MY110074A (en) Pharmacuetical formulation.
ZA925130B (en) Pharmaceutical formulation.
IT1224701B (it) Preparati farmaceutici antimicrobici per applicazione topica e procedimento per la loro produzione
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
HUP0004475A2 (hu) Gyógyszerkészítmény
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees